Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
August 26, 2002
- PRESS SEMINAR
August 26, 2002
- BULLETIN -1-
August 26, 2002
- WEBSITE NEWS
August 26, 2002
- GCP Revision to Follow PAL Amendment
August 26, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 26, 2002
- Outline of New NDA Reviewing Institution Revealed
August 26, 2002
- Large Product Line, Reasonable Prices in Drug Stores Are Appreciated: Survey
August 26, 2002
- Taisho, Toyama Agree to Form Capital, Business Alliance
August 19, 2002
- NEW PRODUCTS
August 19, 2002
- Olympus to Raise Sales to \870 Bil. in 5 Years
August 19, 2002
- MEETING
August 19, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
August 19, 2002
- MEDICAL DEVICE NEWS IN BRIEF
August 19, 2002
- To Further Concentrate on Ethical Drug Business: Takeda President
August 19, 2002
- FY2000 Nat'l Medical Costs Down 1.9% Due to Nursing Care Insurance
August 19, 2002
- DIAGNOSTIC NEWS IN BRIEF
August 19, 2002
- Kyowa Hakko to Start SMART Marketing Strategy in October
August 19, 2002
- Korosho Official Briefs on "General Manufacturing and Marketing Managers"
August 19, 2002
- WORLD NEW IN BRIEF
August 19, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…